Drug Therapy
Dual antiplatelet therapy for acute coronary syndromes: How long to continue?After drug-eluting stent placement, at least 12 months of dual antiplatelet therapy is recommended. Would longer be better?
- Is a serum TSH measurement sufficient to monitor the treatment of primary hypothyroidism?
Yes, the TSH level provides the information you need to manage primary hypothyroidism.
- Your patient has chronic leukemia: Now what?
New therapies for chronic myelogenous leukemia and chronic lymphocytic leukemia are increasing the number of survivors.
- Is there a time limit for systemic menopausal hormone therapy?
The duration needs to be an individualized, shared decision that is reassessed annually.
Anemia of chronic kidney disease: Treat it, but not too aggressivelyRenal anemia is associated with bad outcomes, but attempting to normalize hemoglobin levels can be harmful.
- The fifth vital sign: A complex story of politics and patient care
Times have changed, and the diffi culties and complexities of trying to help patients with ongoing pain have increased.
- Anticoagulation in dental surgery: Is it rude to interrupt?
Anticoagulation should not be interrupted for dental surgery.
- Navigating pneumococcal vaccination in adults
With two nonequivalent vaccines and different schedules for different groups, vaccination can be confusing.